Stanford Webinar - A Conversation on the Future of Translational Medicine

Overview

Dean Felsher and Joanna Lilienthal discuss the evolving landscape of translational research, emphasizing the blurring boundaries between discovery, development, and commercialization. They highlight the critical need for interdisciplinary collaboration, the impact of AI and computational biology on accelerating discoveries, and the TRAM (Translational Research and Applied Medicine) program at Stanford, which fosters this ecosystem through education, project support, and networking to improve patient lives.

Key takeaways

Translational research is characterized by the blurring of lines between basic discovery, clinical development, and commercialization, requiring early consideration of downstream factors.
AI and computational biology are significantly accelerating the pace of discovery in medicine, with a growing number of students focusing on these areas.
The TRAM program at Stanford acts as an 'ecosystem' that connects clinicians, scientists, industry experts, and learners, fostering collaboration and providing comprehensive education across the translational spectrum.
Effective translational research necessitates interdisciplinary teams where individuals from diverse backgrounds (science, medicine, business, law) collaborate, leveraging each other's expertise.
Stanford's TRAM program offers both master's degrees and graduate certificates to equip professionals with the knowledge and network to become leaders in medical translation, applicable to therapeutics, diagnostics, devices, and computational platforms.
The program's success relies on cultivating a collaborative spirit and a continuous learning environment, encouraging participants to become leaders and team players who contribute to the broader translational medicine community.

Chapters

0:00 Introduction to Translational Research and Housekeeping

Welcome and introduction of Dean Felsher and Joanna Lilienthal.
Overview of webinar housekeeping: Q&A submission and recording availability.
Introduction to the topic: the future of translational research.

0:17 Defining Translational Research and Its Challenges

Dean Felsher defines translational research as moving laboratory discoveries to real-world applications like treatments or diagnostics.
Joanna Lilienthal highlights challenges: drug development requires more than science, needing input from manufacturing, IP, and commercialization.
The difficulty for scientists and clinicians to communicate and understand each other's needs is a primary barrier.

10:41 The Disappearing Boundaries Between Research Stages

Joanna Lilienthal notes that the traditional sequential stages of discovery, development, and commercialization are now overlapping.
Downstream questions (regulatory, commercial) must be considered much earlier in the research process.
AI, computational approaches, biomarkers, and patient selection are increasingly influencing early-stage scientific work.

15:01 MYC Oncogene: A Case Study in Translational Challenges

Dean Felsher uses the MYC oncogene, involved in most human cancers, as an example of a long-known scientific concept with delayed translation.
Translating MYC research requires understanding clinical circumstances, chemistry, and targeting strategies.
The TRAM program aims to integrate world-class chemistry, clinical insights, and basic science to tackle such problems.

19:01 The Evolving Field: Beyond Siloed Expertise

Translational research now requires awareness across all stages, from scientific questions to regulatory approval and adoption.
The field emphasizes breaking down silos and fostering a holistic understanding of the entire ecosystem.
Joanna Lilienthal facilitates cross-disciplinary collaborations, connecting experts from different fields like psychiatry and immunology.

24:01 Impact of AI and Computational Biology on Discovery

AI and computational biology have dramatically accelerated discoveries in medicine over the last five years.
A significant portion of TRAM's current cohort is focused on solving problems using AI and computational biology.
TRAM's core value is connecting the right people, fostering collaborations between diverse fields like cardiology and infectious disease.

28:21 TRAM's Organic Evolution and Experiential Learning

The TRAM program organically evolves with students, fellows, and faculty, leveraging Stanford's brilliance.
New courses are added to cover emerging areas like diagnostics, vaccine therapy, and AI mentorship.
Experiential components, including individual TREP projects and multidisciplinary team projects, are greatly expanded.

34:10 Why Broader Understanding is Crucial for All Professionals

Dean Felsher explains that understanding the full spectrum of translational science is crucial for medical doctors, basic scientists, and business professionals.
Advances in science and bioinformatics are accelerating translation, making it vital to stay current.
Education programs provide a framework to understand how diagnostics, therapeutics, and healthcare delivery are changing.

40:24 TRAM as an Ecosystem: Education, Projects, and Collaborations

Joanna Lilienthal describes TRAM as an ecosystem supporting clinicians, scientists, industry experts, and entrepreneurs.
The program provides education, mentorship, project support, and facilitates collaborations to move science forward and improve patient lives.
The Master's in Translational Research and Applied Medicine (M-TRAM) and graduate certificates are key educational offerings.

46:51 Curriculum Structure and Network Building

The curriculum covers the entire arc of translation, from forming scientific questions to regulatory approval and commercialization.
Courses include specific topics like chemistry, patent law, vaccine development, and clinical study design.
Graduates become part of a vast network, maintaining connections and supporting each other throughout their careers.

Summary, takeaways, and chapters were generated by AI from the video's transcript and may contain errors. The video belongs to its creator, Stanford Online.